🇺🇸 FDA
Pipeline program

Comirnaty JN.1 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, LVT-001

DR230330 – ANRS0514s

Phase 2 small_molecule active

Quick answer

Comirnaty JN.1 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, LVT-001 for Healthy volunteers is a Phase 2 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).

Program details

Company
Tour Hekla
Indication
Healthy volunteers
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials